Cargando…
Searching for a Paradigm Shift in Auger-Electron Cancer Therapy with Tumor-Specific Radiopeptides Targeting the Mitochondria and/or the Cell Nucleus
Although (99m)Tc is not an ideal Auger electron (AE) emitter for Targeted Radionuclide Therapy (TRT) due to its relatively low Auger electron yield, it can be considered a readily available “model” radionuclide useful to validate the design of new classes of AE-emitting radioconjugates. With this in...
Autores principales: | Fernandes, Célia, Palma, Elisa, Silva, Francisco, Belchior, Ana, Pinto, Catarina I. G., Guerreiro, Joana F., Botelho, Hugo M., Mendes, Filipa, Raposinho, Paula, Paulo, António |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9266350/ https://www.ncbi.nlm.nih.gov/pubmed/35806239 http://dx.doi.org/10.3390/ijms23137238 |
Ejemplares similares
-
Evaluation of Acridine Orange Derivatives as DNA-Targeted Radiopharmaceuticals for Auger Therapy: Influence of the Radionuclide and Distance to DNA
por: Pereira, Edgar, et al.
Publicado: (2017) -
Synthesis and Biological Evaluation of (99m)Tc(I) Tricarbonyl Complexes Dual-Targeted at Tumoral Mitochondria
por: Figueiredo, Diogo, et al.
Publicado: (2021) -
Successful radiopeptide targeting of metastatic anaplastic meningioma: Case report
por: Sabet, Amir, et al.
Publicado: (2011) -
Women in the field of multiple sclerosis: How they contributed to paradigm shifts
por: Barateiro, Andreia, et al.
Publicado: (2023) -
Can DCE-MRI Explain the Heterogeneity in Radiopeptide Uptake Imaged by SPECT in a Pancreatic Neuroendocrine Tumor Model?
por: Bol, Karin, et al.
Publicado: (2013)